These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28942732)

  • 1. Is Graves' disease a primary immunodeficiency? New immunological perspectives on an endocrine disease.
    Struja T; Kutz A; Fischli S; Meier C; Mueller B; Recher M; Schuetz P
    BMC Med; 2017 Sep; 15(1):174. PubMed ID: 28942732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalised immunomodulating treatments for Graves' disease: fact or fiction?
    Struja TM; Kutz A; Fischli S; Meier C; Müller B; Schütz P
    Swiss Med Wkly; 2017; 147():w14476. PubMed ID: 28804863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and classification of Graves' disease.
    Menconi F; Marcocci C; Marinò M
    Autoimmun Rev; 2014; 13(4-5):398-402. PubMed ID: 24424182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graves' disease and Graves' orbitopathy following COVID-19.
    Lanzolla G; Marcocci C; Marinò M
    J Endocrinol Invest; 2021 Sep; 44(9):2011-2012. PubMed ID: 33964007
    [No Abstract]   [Full Text] [Related]  

  • 6. Etiopathogenesis of Graves' disease.
    Karasek M; Lewinski A
    Neuro Endocrinol Lett; 2003; 24(3-4):161-6. PubMed ID: 14523350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid surgery for Graves' disease and Graves' ophthalmopathy.
    Liu ZW; Masterson L; Fish B; Jani P; Chatterjee K
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010576. PubMed ID: 26606533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New perspectives for the diagnosis and prognosis of Graves' disease].
    Tatulashvili S; Baudry C; Sadoul JL; Bihan H
    Ann Endocrinol (Paris); 2018 Sep; 79 Suppl 1():S31-S39. PubMed ID: 30213303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of genetics in Graves' disease and thyroid orbitopathy.
    Kim N; Hatton MP
    Semin Ophthalmol; 2008; 23(1):67-72. PubMed ID: 18214794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
    Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
    Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease.
    Jaspan JB; Sullivan K; Garry RF; Lopez M; Wolfe M; Clejan S; Yan C; Tenenbaum S; Sander DM; Ahmed B; Bryer-Ash M
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2271-9. PubMed ID: 8964863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thyroid, the eyes and the gut: a possible connection.
    Covelli D; Ludgate M
    J Endocrinol Invest; 2017 Jun; 40(6):567-576. PubMed ID: 28063079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
    Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
    Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current insights into animal models of Graves' disease and orbitopathy.
    Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
    Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.
    Ahmann A; Baker JR; Weetman AP; Wartofsky L; Nutman TB; Burman KD
    J Clin Endocrinol Metab; 1987 Mar; 64(3):454-60. PubMed ID: 2434519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves' patients.
    Wiebolt J; Achterbergh R; den Boer A; van der Leij S; Marsch E; Suelmann B; de Vries R; van Haeften TW
    Eur J Endocrinol; 2011 May; 164(5):789-94. PubMed ID: 21378091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy.
    Bufalo NE; Dos Santos RB; Marcello MA; Piai RP; Secolin R; Romaldini JH; Ward LS
    J Endocrinol Invest; 2015 May; 38(5):555-61. PubMed ID: 25543543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tale of radioiodine and Graves' orbitopathy.
    Ponto KA; Zang S; Kahaly GJ
    Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
    Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.